143 related articles for article (PubMed ID: 6778991)
1. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
Venkataramanan R; Axelson JE
J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent pharmacokinetics of tocainide in the rat.
Venkataramanan R; Axelson JE
J Pharmacol Exp Ther; 1980 Oct; 215(1):231-4. PubMed ID: 6778990
[TBL] [Abstract][Full Text] [Related]
3. Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase.
Elvin AT; Lalka D; Stoeckel K; du Souich P; Axelson JE; Golden LH; McLean AJ
Clin Pharmacol Ther; 1980 Nov; 28(5):652-8. PubMed ID: 6777107
[TBL] [Abstract][Full Text] [Related]
4. Disposition of (R,S)-tocainide. Some stereoselective aspects.
Gal J; French TA; Zysset T; Haroldsen PE
Drug Metab Dispos; 1982; 10(4):399-404. PubMed ID: 6126341
[TBL] [Abstract][Full Text] [Related]
5. Disposition of medroxyprogesterone acetate and drug metabolism activity.
Saarni HU; Rautio A; Kärki NT; Sotaniemi EA
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):251-60. PubMed ID: 6221375
[TBL] [Abstract][Full Text] [Related]
6. Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.
Reddy CS; Reddy RV; Hayes AW
J Toxicol Environ Health; 1983; 12(4-6):687-94. PubMed ID: 6668617
[TBL] [Abstract][Full Text] [Related]
7. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
Aldous CN; Chetty CS; Desaiah D
J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
[TBL] [Abstract][Full Text] [Related]
8. Influence of rifampin on tocainide pharmacokinetics in humans.
Rice TL; Patterson JH; Celestin C; Foster JR; Powell JR
Clin Pharm; 1989 Mar; 8(3):200-5. PubMed ID: 2495879
[TBL] [Abstract][Full Text] [Related]
9. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
10. Alteration of delta 9-tetrahydrocannabinol-induced teratogenicity by stimulation and inhibition of its metabolism.
Harbison RD; Mantilla-Plata B; Lubin DJ
J Pharmacol Exp Ther; 1977 Aug; 202(2):455-65. PubMed ID: 886474
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
Siemann DW
Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
[TBL] [Abstract][Full Text] [Related]
12. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
Chang TK; Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
[TBL] [Abstract][Full Text] [Related]
13. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
[TBL] [Abstract][Full Text] [Related]
14. Effects of pretreatment with SKF-525A, N-Methyl-2-thioimidazole, sodium phenobarbital, or methyl cholanthrene on ethylenethiourea-induced teratogenicity in rats.
Khera KS; Iverson F
Teratology; 1981 Oct; 24(2):131-7. PubMed ID: 7336357
[TBL] [Abstract][Full Text] [Related]
15. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
Plänitz V; Jähnchen E
Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of paraldehyde to acetaldehyde by rat liver microsomes.
Zera RT; Nagasawa HT
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):531-41. PubMed ID: 7323448
[TBL] [Abstract][Full Text] [Related]
17. Effect of phenobarbital and SKF 525A on the toxicity, elimination and metabolism of cyclophosphamide in newborn mice.
Bus JS; Short RD; Gibson JE
J Pharmacol Exp Ther; 1973 Mar; 184(3):749-56. PubMed ID: 4687235
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
[TBL] [Abstract][Full Text] [Related]
19. Effects of phenobarbital and SKF-525A on in vitro hepatic metabolism of verapamil and nifedipine.
Hamann SR; Tan TG; Kaltenborn KE; Brouwer KL; Blouin RA; Chang SL; Vore M; McAllister RG
Pharmacology; 1985; 30(3):121-8. PubMed ID: 3975261
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition.
Hayball PJ; Meffin PJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):631-6. PubMed ID: 3806416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
